Peptide Libraray

AmphiArc2 Off2.2.9

General Information

DCTPep ID DCTPep02798

Peptide Name AmphiArc2 Off2.2.9

Sequence QLLKKIRTWYRKAWHVYGKV

Sequence Length 20

UniProt ID Not available

PubChem CID Not available

Origin Synthetic

Type Synthetic peptide

Classification

ACP Tumor active peptide Membrane-targeted

Activity Information

Cell Line	Disease	Activity	Assay	Testing Time	Literature
MCF-7	Invasive breast carcinoma of no special type	EC50=13 ± 1 µM	MTT assay	24 h	1
A549	Lung adenocarcinoma	EC50=28 ± 3 µM	MTT assay	24 h	1

Hemolytic Activity Human erythrocytes: HC50>200 µM

Normal (non-cancerous) Cytotoxicity HDMEC: EC50=21 ± 2 µM

Target Not available

Affinity Not available

Mechanism Not available

Structure Information

PDB ID Not available

Predicted Structure DCTPep02798

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity Not available

Linear/Cyclic Linear

Disulfide/Other Bond Not available

N-terminal Modification Free

C-terminal Modification Free

Other Modification None

Chiral L

Physicochemical Information

Formula C124H193N35O25

Absent amino acids CDEFMNPS

Theoretical pI 10.66

Acidic residues 0

Basic residues 7

Polar residues 4

Molecular weight (Average) 2574.12

Molecular weight (Monoisotopic) 2572.49

Common amino acids K

Net charge 7

Instability index (II) -19.63

Aliphatic index 92.50

Grand average of hydropathicity (GRAVY) -0.725

Half Life
0.8 hours (mammalian reticulocytes, in vitro).
10 min (yeast, in vivo).
10 hours (Escherichia coli, in vivo).

Extinction coefficients
Ext. coefficient 13980
Abs 0.1% (=1 g/l) 5.431

Amino acid distribution

Literature Information

Literature 1

Pubmed ID 31375699

Title In silico design and optimization of selective membranolytic anticancer peptides

Doi 10.1038/s41598-019-47568-9

Year 2019

Patent

Patent ID Not available

Patent Title Not available

Other Iinformation Not available

Other Published ID Not available

External Code

DBAASP ID DBAASPS_16623